Skip to content

Resuscitative TEE Collaborative Registry

Evaluation of the Clinical Impact and Safety of Focused Transesophageal Echocardiography During Resuscitation of Critically Ill Patients in the Emergency Department and Intensive Care Settings

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04972526
Acronym
rTEECoRe
Enrollment
1000
Registered
2021-07-22
Start date
2020-12-01
Completion date
2027-12-15
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Cardiac Arrest Circulatory, Cardiac Arrest, Out-Of-Hospital, Hemodynamic Instability, Shock

Keywords

Transesophageal Echocardiography, Resuscitation, Cardiac Arrest, Point-of-care Ultrasound, Focused Cardiac Ultrasound

Brief summary

The general objective of this study is to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill patients in the emergency and intensive care settings. The target population for this study are critically-ill patients over the age of 18 who as part of their routine clinical care are receiving a focused TEE. The primary objective of this study is to determine the clinical impact and safety of TEE performed during the evaluation of critically-ill patients in the emergency department and intensive care settings. The secondary objective(s) of this study are to characterize the use of this imaging modality in the subsets of critically-ill patients in shock and cardiac arrest; including but not limited to; description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.

Detailed description

Vision The Resuscitative TEE Collaborative Registry aims to accelerate the development of outcome-oriented research and knowledge translation on the use of TEE in emergency and critical care settings. Mission The registry aims to catalyze clinical research involving the use of TEE in critically-ill patients through the following strategic initiatives: * Facilitate collaboration between different clinical teams and organizations across the entire spectrum of users of TEE in acute care setting, including emergency departments and intensive care units. * Standardize data collection and reporting that enables multi-institutional data sharing. * Provide an efficient research infrastructure that facilitates data capture, management and analysis, enabling teams around the world to conduct research studies in this field. * Make shared data open and accessible to clinicians and researchers.

Interventions

None listed

Sponsors

University of Pennsylvania
Lead SponsorOTHER
Weill Medical College of Cornell University
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting.

Exclusion criteria

* Children (age under 18 years) * Vulnerable populations

Design outcomes

Primary

MeasureTime frameDescription
The clinical impact and safety of TEE performed during the evaluation of critically ill patients in the emergency department and intensive care settings.From the time of admission to the hospital until the date of discharge from the hospital or date of death from any cause, whichever occurs first, assessed up to 12 weeksDetermination of ROSC and survival to hospital discharge

Secondary

MeasureTime frameDescription
The use of the TEE imaging modality in subsets of critically-ill patients in shock and cardiac arrest.From the time of admission to the hospital until the date of discharge from the hospital or date of death from any cause, whichever occurs first, assessed up to 12 weeksDescription of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.

Countries

United States

Contacts

CONTACTJames R Quinlan
jrq6@cornell.edu7175792198
CONTACTFelipe Teran, MD, MSCE
9172573841
PRINCIPAL_INVESTIGATORFelipe Teran, MD, MSCE

Weill Medical College of Cornell University

STUDY_CHAIRClark G Owyang, MD

Weill Medical College of Cornell University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026